ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,254.18
-0.76%
Dow Jones
38,852.86
-0.55%
Gold vs US Dollar
2,361.11
0.39%
Brent Oil
84.325
1.79%
Bitcoin
68,223.53
-1.69%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. HOOKIPA Pharma Inc (HOOK) Share Price

HOOK HOOKIPA Pharma Inc

0.7801
-0.0199 (-2.49%)
After Hours
Last Updated: 21:59:39
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 HOOKIPA Pharma Inc NASDAQ:HOOK NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   -0.0199 -2.49 0.7801 0.7802 0.7951 0.842514 0.78 0.8 686,855 20:59:39   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 20.13M -81.58M -0.9718 -0.80 65.48M
 Type  Size  Price  Time  Units 
 9 10 0.78 20:43:20 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore HOOK News
23/05/202422:05EDGAR2Form 8-K - Current report
23/05/202422:01GLOBEHOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
09/05/202412:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/05/202412:03EDGAR2Form 8-K - Current report
09/05/202412:01GLOBEHOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
25/04/202412:01GLOBEHOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
24/04/202412:01GLOBEHOOKIPA Pharma Announces FDA Clearance of its Investigational New Drug Application for HB-700 for the Treatment of KRAS-Mutated Cancers
Period
Draw mode
Data Downloads for HOOK

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest HOOKIPA Pharma Inc Articles